These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 24283856

  • 21. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY, Mao L, Li L, Tian Z, Zhou XJ, Zhang ZY, Li J.
    Cancer; 2007 Jul 01; 110(1):87-95. PubMed ID: 17520682
    [Abstract] [Full Text] [Related]

  • 22. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.
    Molina JR, Aubry MC, Lewis JE, Wampfler JA, Williams BA, Midthun DE, Yang P, Cassivi SD.
    Cancer; 2007 Nov 15; 110(10):2253-9. PubMed ID: 17918258
    [Abstract] [Full Text] [Related]

  • 23. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma.
    Bell D, Bell A, Roberts D, Weber RS, El-Naggar AK.
    Cancer; 2012 Mar 01; 118(5):1288-92. PubMed ID: 21800291
    [Abstract] [Full Text] [Related]

  • 24. Management of adenoid cystic carcinoma of minor salivary glands.
    Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D.
    J Oral Maxillofac Surg; 2006 Jul 01; 64(7):1114-20. PubMed ID: 16781345
    [Abstract] [Full Text] [Related]

  • 25. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
    Ferrazzo KL, Alves SM, Santos E, Martins MT, de Sousa SM.
    Oral Oncol; 2007 Jul 01; 43(6):580-5. PubMed ID: 16996782
    [Abstract] [Full Text] [Related]

  • 26. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
    Safoura S, Mohamad E, Nosrat-Allah E, Fereshte E.
    J Cancer Res Ther; 2011 Jul 01; 7(1):23-8. PubMed ID: 21546738
    [Abstract] [Full Text] [Related]

  • 27. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
    Penner CR, Folpe AL, Budnick SD.
    Mod Pathol; 2002 Jul 01; 15(7):687-91. PubMed ID: 12118104
    [Abstract] [Full Text] [Related]

  • 28. RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.
    Zhang CY, Zhao YX, Xia RH, Han J, Wang BS, Tian Z, Wang LZ, Hu YH, Li J.
    PLoS One; 2014 Jul 01; 9(10):e110159. PubMed ID: 25302792
    [Abstract] [Full Text] [Related]

  • 29. [Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands].
    Huang M, Ma D, Sun K.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Nov 01; 35(6):430-3. PubMed ID: 11780525
    [Abstract] [Full Text] [Related]

  • 30. TUNEL - an efficient prognosis predictor of salivary malignancies.
    Ben-Izhak O, Laster Z, Araidy S, Nagler RM.
    Br J Cancer; 2007 Apr 10; 96(7):1101-6. PubMed ID: 17325701
    [Abstract] [Full Text] [Related]

  • 31. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
    Vékony H, Raaphorst FM, Otte AP, van Lohuizen M, Leemans CR, van der Waal I, Bloemena E.
    J Clin Pathol; 2008 Jun 10; 61(6):744-9. PubMed ID: 18326020
    [Abstract] [Full Text] [Related]

  • 32. Expression of EpCAM in adenoid cystic carcinoma.
    Lee SJ, Chung KY, Kwon JE, Yoon SO, Kim SK.
    Pathology; 2018 Dec 10; 50(7):737-741. PubMed ID: 30389218
    [Abstract] [Full Text] [Related]

  • 33. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
    Zhou M, Li Y, Lin S, Chen Y, Qian Y, Zhao Z, Fan H.
    Dig Dis Sci; 2019 Aug 10; 64(8):2147-2157. PubMed ID: 30788686
    [Abstract] [Full Text] [Related]

  • 34. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
    Hirvonen K, Bäck L, Haglund C, Leivo I, Jouhi L, Mäkitie AA, Hagström J.
    Tumour Biol; 2016 Aug 10; 37(8):10959-64. PubMed ID: 26888781
    [Abstract] [Full Text] [Related]

  • 35. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS, Kim YS, Kim DK, Park SI, Jang SJ.
    Pathol Int; 2012 Mar 10; 62(3):182-90. PubMed ID: 22360506
    [Abstract] [Full Text] [Related]

  • 36. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation.
    Matsuba HM, Simpson JR, Mauney M, Thawley SE.
    Head Neck Surg; 1986 Mar 10; 8(3):200-4. PubMed ID: 3017893
    [Abstract] [Full Text] [Related]

  • 37. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
    Rettig EM, Tan M, Ling S, Yonescu R, Bishop JA, Fakhry C, Ha PK.
    Laryngoscope; 2015 Sep 10; 125(9):E292-9. PubMed ID: 25963073
    [Abstract] [Full Text] [Related]

  • 38. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome.
    Beckhardt RN, Weber RS, Zane R, Garden AS, Wolf P, Carrillo R, Luna MA.
    Laryngoscope; 1995 Nov 10; 105(11):1155-60. PubMed ID: 7475867
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P, Andreasen S, Grossmann P, Hauer L, Vaněček T, Miesbauerová M, Santana T, Kiss K, Slouka D, Skálová A.
    Virchows Arch; 2018 Oct 10; 473(4):471-480. PubMed ID: 29619555
    [Abstract] [Full Text] [Related]

  • 40. Minor salivary gland tumors of the oral cavity: a case series with review of literature.
    Vaidya AD, Pantvaidya GH, Metgudmath R, Kane SV, D'Cruz AK.
    J Cancer Res Ther; 2012 Jan 10; 8 Suppl 1():S111-5. PubMed ID: 22322728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.